SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 15, 2011
The New York Times Company
(Exact name of registrant as specified in its charter)
Registrants telephone number, including area code: (212) 556-1234
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
(b) On June 15, 2011, Dawn G. Lepore informed The New York Times Company (the Company) of her decision to resign from the Companys Board of Directors, effective on that date, in order to pursue other professional interests. Ms. Lepore was Chairman, President and Chief Executive Officer of drugstore.com, inc., a publicly traded online provider of health, beauty, vision and pharmacy products, until its acquisition by Walgreens on June 3, 2011. Ms. Lepore is currently serving as a strategic advisor to Walgreens for a transition period. Ms. Lepores decision to resign as a director was not due to any disagreements with the Company on any matter relating to the Companys operations, policies or practices. Ms. Lepore had served as a Director of the Company since 2008, and was a member of the Audit Committee and Compensation Committee.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.